['DRUG INTERACTIONS ASSOCIATED WITH INCREASED RISK OF MYOPATHY/RHABDOMYOLYSIS ( 2.6 , 5.1 , 7 , 12.3 )', 'INTERACTING AGENTS', 'PRESCRIBING RECOMMENDATIONS', 'CYCLOSPORINE, HIV PROTEASE INHIBITORS (TIPRANAVIR PLUS RITONAVIR), HEPATITIS C PROTEASE INHIBITOR (TELAPREVIR)', 'AVOID ATORVASTATIN', 'HIV PROTEASE INHIBITOR (LOPINAVIR PLUS RITONAVIR)', 'USE WITH CAUTION AND LOWEST DOSE NECESSARY', 'CLARITHROMYCIN, ITRACONAZOLE, HIV PROTEASE INHIBITORS (SAQUINAVIR PLUS RITONAVIR, DARUNAVIR PLUS RITONAVIR, FOSAMPRENAVIR, FOSAMPRENAVIR PLUS RITONAVIR)', 'DO NOT EXCEED 20 MG ATORVASTATIN DAILY', 'HIV PROTEASE INHIBITOR (NELFINAVIR) HEPATITIS C PROTEASE INHIBITOR (BOCEPREVIR)', 'DO NOT EXCEED 40 MG ATORVASTATIN DAILY']